大北農(002385.SZ):子公司的投資新型獸用生物製品生產車間改擴建項目擬增加投資
格隆匯11月2日丨大北農(002385.SZ)公佈,公司第五屆董事會第二十八次臨時會議審議通過了《關於控股子公司(兆豐華生物科技(南京)有限公司)投資新型獸用生物製品生產車間改擴建項目增加投資的議案》、《關於控股子公司(兆豐華生物科技(福州)有限公司)投資新型獸用生物製品生產車間改擴建項目增加投資的議案》。上述對外投資事項不構成關聯交易,也不構成重大資產重組,不需要提交股東大會審議。
2020年10月23日,公司召開第五屆董事會第十次會議審議通過了《關於控股子公司(兆豐華生物科技(南京)有限公司)投資新型獸用生物製品生產車間改擴建項目的議案》,同意公司投資投資建設新型獸用生物製品生產車間改擴建項目,擬投資總額約為13300萬元。現在因新版GMP驗收要求,車間生產工藝設計調整,項目需增加預算2260萬元,增加後的預算為15560萬元。
2020年10月23日,公司召開第五屆董事會第十次會議審議通過了《關於控股子公司(兆豐華生物科技(福州)有限公司)投資新型獸用生物製品生產車間改擴建項目的議案》,同意公司投資投資建設新型獸用生物製品生產車間改擴建項目,擬投資總額約12635萬元。現因新版GMP驗收要求,車間生產工藝設計調整,需要增加預算5165萬元,增加後的預算為17800萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.